Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

NCRM, CSCRM to become national force in regenerative medicine

In a move to streamline and accelerate the research and development of new stem cell and regenerative medicine technologies, the National Center for Regenerative Medicine and the Center for Stem Cell and Regenerative Medicine at Case Western Reserve University have been rolled into a single entity housed within the university's School of Medicine.

5 Mar 2011

Efficient medical treatments to be showcased at SIR's 36th Annual Scientific Meeting

The Society of Interventional Radiology will feature minimally invasive scientific advances and new discoveries in treating a host of diseases at its 36th Annual Scientific Meeting March 26–31 at McCormick Place (West) in Chicago, Ill. The theme of the meeting is "IR Rising: Leading Image-guided Medicine," chosen to reflect interventional radiology's continued revolutionizing of modern medicine.

5 Mar 2011

Biosante to purchase $25.1 million shares of common stock in registered direct offering

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.

5 Mar 2011

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.

5 Mar 2011

NCI renews Ariadne's license for Pathway Studio Enterprise system

Ariadne, a leader in bioinformatics software and knowledge integration, announced that National Cancer Institute has renewed their license for Pathway Studio Enterprise system that includes the ResNet Mammalian database and Ariadne MedScan text processing technology for site-wide use.

5 Mar 2011

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.

5 Mar 2011

Caris Life Sciences to highlight new approaches for gynecologic cancers at SGO 2011 conference

Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced highlights from the company's upcoming symposium, "Using Biomarker Expression to Guide Therapy: An Evidence-Based Approach for Gynecologic Cancers," at the Society of Gynecologic Oncologists 2011 Annual Meeting on Women's Cancer in Orlando, FL on March 6.

5 Mar 2011

BNCT treatment proves effective in treating recurrent head, neck cancer

Biologically targeted BNCT treatment is based on producing radiation inside a tumour using boron-10 and thermal neutrons. Boron-10 is introduced into cancer cells with the help of a special carrier substance (phenylalanine), after which the tumour is irradiated with lowenergy neutrons.

5 Mar 2011

PRI, AnswersMedia announce launch of Patient Advisor

Prescribing Reference, Inc. and AnswersMedia, LLC today announced the launch of Patient Advisor, an educational online resource for drug, health, and nutrition information that enables consumers to make better informed healthcare and lifestyle decisions.

5 Mar 2011

Article outlines role of transcriptional mutagenesis in tumor development

DNA provides the instruction manual for all life forms. Occasionally, instructions are not carried out properly, and bad messages are sent leading to the creation of mutant proteins and possible tumor development.

5 Mar 2011

NorthShore receives $1.5 million gift to establish center for the study of complex diseases

NorthShore University HealthSystem (NorthShore) Foundation has received a $1.5 million gift for the creation of the Center for the Study of Complex Diseases. The development of the Center, which is being established within the NorthShore Research Institute, is made possible through a generous gift by Mr. and Mrs. Richard L. Keyser of Glencoe, Ill., through the Keyser Family Research Fund.

4 Mar 2011

European Commission approves BMY's ONGLYZA to treat type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.

4 Mar 2011

Cancer patients' willingness to undergo tests bodes well for future of personalized medicine

Cancer patients are willing to undergo many tests to receive advanced experimental treatment in clinical trials, according to a new study by Mayo Clinic, Scottsdale Healthcare and the Translational Genomics Research Institute.

4 Mar 2011

Varian to highlight new digital image detectors and X-ray tubes at ECR annual meeting

Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the European Congress of Radiology (ECR) annual meeting in Vienna, Austria this week.

4 Mar 2011

BioSante vaccine increases median survival of resected pancreatic cancer patients

BioSante Pharmaceuticals, Inc. today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent.

4 Mar 2011

U.S. Representatives, Gene Green introduce bipartisan bill to ensure Medicare reimbursement

U.S. Representatives Ed Whitfield and Gene Green today introduced H.R. 905.

4 Mar 2011

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

Allos Therapeutics, Inc. today announced that the Company has reached agreement with the U.S. Food and Drug Administration (FDA) under its Special Protocol Assessment (SPA) process for the design of the Company's Phase 3 clinical trial of FOLOTYN® (pralatrexate injection) in patients with previously undiagnosed peripheral T-cell lymphoma (PTCL).

4 Mar 2011

First artificial bronchus graft in a lung cancer patient successful

In a medical breakthrough French surgeons have grafted an artificial airway to save a lung afflicted by bronchial cancer in a 78-year-old man. The bronchi are the main tubes or airways used for taking air from the trachea to the two sides of the lung.

3 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.

3 Mar 2011

Oncology News and Research

Further Reading

NCRM, CSCRM to become national force in regenerative medicine

Efficient medical treatments to be showcased at SIR's 36th Annual Scientific Meeting

Biosante to purchase $25.1 million shares of common stock in registered direct offering

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

NCI renews Ariadne's license for Pathway Studio Enterprise system

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

Caris Life Sciences to highlight new approaches for gynecologic cancers at SGO 2011 conference

BNCT treatment proves effective in treating recurrent head, neck cancer

PRI, AnswersMedia announce launch of Patient Advisor

Article outlines role of transcriptional mutagenesis in tumor development

NorthShore receives $1.5 million gift to establish center for the study of complex diseases

European Commission approves BMY's ONGLYZA to treat type 2 diabetes

Cancer patients' willingness to undergo tests bodes well for future of personalized medicine

Varian to highlight new digital image detectors and X-ray tubes at ECR annual meeting

BioSante vaccine increases median survival of resected pancreatic cancer patients

U.S. Representatives, Gene Green introduce bipartisan bill to ensure Medicare reimbursement

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

First artificial bronchus graft in a lung cancer patient successful

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News